Summary
Library
Plain computed tomography scan showing a small pituitary mass encroaching on the right cavernous sinus
(A) Coronal T1 weighted magnetic resonance imaging (MRI) scan showing a pituitary mass with expansion of the pituitary fossa. (B) Coronal T1 weighted MRI scan showing a pituitary mass extending into the cavernous sinus, particularly on the right. (C) Sagittal T1 weighted MRI scan of the pituitary tumor
Coronal (A) and sagittal (B) post-contrast magnetic resonance image T1 weighted sections showing a large intrasellar tumor with suprasellar component. Suprasellar solid component shows a lobulated margin with peripheral non-enhancing cystic areas (margins shown by arrows), which are mildly hyperintense compared with cerebrospinal fluid in basal cisterns
Citations
Tritos NA, Miller KK. Diagnosis and management of pituitary adenomas: a review. JAMA. 2023 Apr 25;329(16):1386-98.[Abstract]
Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:894-904.[Abstract][Full Text]
American College of Radiology. ACR appropriateness criteria. Neuroendocrine Imaging. 2018 [internet publication].[Full Text]
1. Tritos NA, Miller KK. Diagnosis and management of pituitary adenomas: a review. JAMA. 2023 Apr 25;329(16):1386-98.[Abstract]
2. Pal A, Leaver L, Wass J. Pituitary adenomas. BMJ. 2019 Jun 6;365:l2091.[Abstract]
3. Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. 2022 Mar;33(1):6-26.[Abstract]
4. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001 Dec;8(4):287-305.[Abstract][Full Text]
5. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004 Aug 1;101(3):613-9.[Abstract][Full Text]
6. Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.[Abstract][Full Text]
7. Wildemberg LE, Fialho C, Gadelha MR. Prolactinomas. Presse Med. 2021 Dec;50(4):104080.[Abstract][Full Text]
8. Daly AF, Beckers A. The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. 2020 Sep;49(3):347-55.[Abstract]
9. Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281-93.[Abstract][Full Text]
10. Giuffrida G, Crisafulli S, Ferraù F, et al. Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies. J Endocrinol Invest. 2022 Jun;45(6):1235-46.[Abstract]
11. Crisafulli S, Luxi N, Sultana J, et al. Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol. 2021 Jul 1;185(2):251-63.[Abstract]
12. Mercado M, Melgar V, Salame L, et al. Clinically non-functioning pituitary adenomas: pathogenic, diagnostic and therapeutic aspects. [in spa]. Endocrinol Diabetes Nutr. 2017 Aug-Sep;64(7):384-95.[Abstract]
13. Shukla P, Bulsara KR, Luthra P. Pituitary hyperplasia in severe primary hypothyroidism: a case report and review of the literature. Case Rep Endocrinol. 2019;2019:2012546.[Abstract][Full Text]
14. Cancer Research UK. Carniopharyngioma. Feb 2023 [internet publication].[Full Text]
15. Kucharczyk W, Truwit CL. Diseases of the sella turcica and parasellar region. In: Hodler J, Kubik-Huch RA, von Schulthess GK, eds. Diseases of the brain, head and neck, spine 2020-2023: diagnostic imaging [Internet]. Cham (CH): Springer; 2020. Chapter 1.[Abstract][Full Text]
16. Keles A, Olsen HT, Nisbet AF, et al. Primary midbrain germinomas: report of a rare case with an updated review of the literature. Clin Neurol Neurosurg. 2023 Apr;227:107643.[Abstract]
17. Abucham J, Dias ML. Pituitary and other sellar region metastases. Curr Opin Endocrinol Metab Res. 2018 Aug;1:36-41.
18. Schubiger O, Haller D. Metastases to the pituitary-hypothalamic axis: an MR study of 7 symptomatic patients. Neuroradiology. 1992;34:131-134.[Abstract]
19. Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer. 1997 Feb 15;79(4):804-12.[Abstract][Full Text]
20. Beauchesne P, Trouillas J, Barral F, et al. Gonadotropic pituitary carcinoma: case report. Neurosurgery. 1995 Oct;37(4):810-5; discussion 815-6.[Abstract]
21. Kaltsas GA, Nomikos P, Kontogeorgos G, et al. Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab. 2005 May;90(5):3089-99.[Abstract][Full Text]
22. Heaney AP. Clinical review: Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab. 2011;96:3649-3660.[Abstract]
23. Joshi MN, Whitelaw BC, Carroll PV. Mechanisms in Eendocrinology: hypophysitis: diagnosis and treatment. Eur J Endocrinol. 2018 Jun 7;179(3):R151-63.[Abstract]
24. Faje AT, Sullivan R, Lawrence D, et al. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab. 2014 Nov;99(11):4078-85.[Abstract][Full Text]
25. Min L, Hodi FS, Giobbie-Hurder A, et al. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 Feb 15;21(4):749-55.[Abstract][Full Text]
26. Torino F, Barnabei A, Paragliola RM, et al. Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol. 2013 Dec;169(6):R153-64.[Abstract][Full Text]
27. Mallereau CH, Todeschi J, Ganau M, et al. Pituitary abscess: a challenging preoperative diagnosis-a multicenter study. Medicina (Kaunas). 2023 Mar 14;59(3):565.[Abstract][Full Text]
28. Heshmati HM, Fatourechi V, Dagam SA, et al. Hypopituitarism caused by intrasellar aneurysms. Mayo Clin Proc. 2001 Aug;76(8):789-93.[Abstract]
29. Goyal P, Utz M, Gupta N, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018 Mar;8(2):219-31.[Abstract][Full Text]
30. Biagetti B, Sarria-Estrada S, Cordero Asanza E, et al. Risk factors, radiological and clinical outcomes in subclinical and clinical pituitary apoplexy. J Clin Med. 2022 Dec 8;11(24):7288.[Abstract][Full Text]
31. Trifanescu R, Ansorge O, Wass JA, et al. Rathke's cleft cysts. Clin Endocrinol (Oxf). 2012 Feb;76(2):151-60.[Abstract][Full Text]
32. Ucciferro P, Anastasopoulou C. Empty sella. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 [Abstract][Full Text]
33. Fernández-Balsells MM, Murad MH, Barwise A, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011 Apr;96(4):905-12.[Abstract][Full Text]
34. Baldeweg SE, Vanderpump M, Drake W, et al. Society for Endocrinology endocrine emergency guidance: emergency management of pituitary apoplexy in adult patients. Endocr Connect. 2016 Sep;5(5):G12-G15.[Abstract][Full Text]
35. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:894-904.[Abstract][Full Text]
36. Chanson P, Maiter D. The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101290.[Abstract][Full Text]
37. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018 May 1;103(5):1715-44.[Abstract][Full Text]
38. Gadelha MR, Kasuki L, Lim DST, et al. Systemic Complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev. 2019 Feb 1;40(1):268-332.[Abstract][Full Text]
39. Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014 Oct 30;99(11):3933-51.[Abstract][Full Text]
40. Beck-Peccoz P, Persani L, Mannavola D, et al. Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):597-606.[Abstract]
41. Cappabianca P, Cirillo S, Alfieri A, et al. Pituitary macroadenoma and diaphragma sellae meningioma: differential diagnosis on MRI. Neuroradiology. 1999;41:22-26.[Abstract]
42. Pinzer T, Krishnan KG, Schackert G. The diaphragma sellae meningioma: a rare differential diagnosis of non-functioning pituitary adenoma. Zentralbl Neurochir. 2004;65:195-197.[Abstract]
43. Scott ES, Long GV, Guminski A, et al. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma. Eur J Endocrinol. 2018 Feb;178(2):173-180.[Abstract][Full Text]
44. Ryder M, Callahan M, Postow MA, et al. Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution. Endocr Relat Cancer. 2014 Apr;21(2):371-81.[Abstract][Full Text]
45. Piloni M, Gagliardi F, Bailo M, et al. Craniopharyngioma in pediatrics and adults. Adv Exp Med Biol. 2023;1405:299-329.[Abstract]
46. Zada G, Ditty B, McNatt SA, et al. Surgical treatment of rathke cleft cysts in children. Neurosurgery. 2009 Jun;64(6):1132-7; author reply 1037-8.[Abstract]
47. Vroonen L, Daly AF, Beckers A. Epidemiology and management challenges in prolactinomas. Neuroendocrinology. 2019;109(1):20-7.[Abstract][Full Text]
48. Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab. 2011;96:1633-1641.[Abstract]
49. Chin BM, Orlandi RR, Wiggins RH 3rd. Evaluation of the sellar and parasellar regions. Magn Reson Imaging Clin N Am. 2012;20:515-543.[Abstract]
50. American College of Radiology. ACR appropriateness criteria. Neuroendocrine Imaging. 2018 [internet publication].[Full Text]
51. Shrivastava RK, Arginteanu MS, King WA, et al. Giant prolactinomas: clinical management and long-term follow up. J Neurosurg. 2002;97:299-306.[Abstract]
52. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273-288.[Abstract][Full Text]
53. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008 May;93(5):1526-40.[Abstract][Full Text]
54. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-75.[Abstract][Full Text]
55. Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016 Nov;101(11):3888-921.[Abstract][Full Text]
56. Jho DH, Biller BM, Agarwalla PK, et al. Pituitary apoplexy: large surgical series with grading system. World Neurosurg. 2014;82:781-790.[Abstract]
Key Articles
Referenced Articles
Sign in to access our clinical decision support tools